On Oct. 10, the FDA classified the recalled prescription medication as a Class II recall. The risk classification from the federal agency indicates that the recalled medications could cause "temporary ...
If you take cholesterol-lowering drugs called statins, you may have noticed a flurry of news coverage since late October about an extensive recall of thousands of bottles of atorvastatin, the generic ...
More than 140,000 bottles of a popular drug commonly prescribed to reduce cholesterol have been recalled for a defect that ...
NEW YORK (CBS.MW) -- Mylan Laboratories said the U.S. Food and Drug Administration has approved its Benazepril Hydrochloride Tablets which are used to treat high blood pressure. Four dosages of the ...
Billionaire investor Carl Icahn has dropped his $5.39 billion offer to buy Mylan Laboratories Inc. and tendered his shares after regulators opened an investigation of a Mylan pain patch that was ...
The chairman and founder of Mylan Laboratories Inc. is deriding financier Carl Icahn as a stock speculator vowing to complete the contested acquisition of King Pharmaceuticals Inc. despite Icahn's ...
LONDON (MarketWatch) -- Pharmaceutical company Mylan Laboratories Inc. said earnings for the first quarter to June 30 fell to $42.9 million, or 16 cents a share, from $82 million, or 30 cents a share, ...
NEW YORK (Reuters) - Mylan Laboratories Inc. said on Thursday that quarterly profit more than doubled, helped by sales of its generic version of the Ditropan XL overactive bladder drug and fentanyl ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback